Abstract:Pulmonary drug delivery systems rely on inhalation of drug-laden aerosols produced from aerosol generators such as inhalers, nebulizers etc. On deposition, the drug molecules diffuse in the mucus layer and are also subjected to mucociliary advection which transports the drugs away from the initial deposition site. The availability of the drug at a particular region of the lung is, thus, determined by a balance between these two phenomena. A mathematical analysis of drug deposition and retention in the lungs is developed through a coupled mathematical model of aerosol transport in air as well as drug molecule transport in the mucus layer. The mathematical model is solved computationally to identify suitable conditions for the transport of drug-laden aerosols to the deep lungs. This study identifies the conditions conducive for delivering drugs to the deep lungs which is crucial for achieving systemic drug delivery. The effect of different parameters on drug retention is also characterized for various regions of the lungs, which is important in determining the availability of the inhaled drugs at a target location. Our analysis confirms that drug delivery efficacy remains highest for aerosols in the size range of 1-5 μ m. Moreover, it is observed that amount of drugs deposited in the deep lung increases by a factor of 2 when the breathing time period is doubled, with respect to normal breathing, suggesting breath control as a means to increase the efficacy of drug delivery to the deep lung. A higher efficacy also reduces the drug load required to be inhaled to produce the same health effects and hence, can help in minimizing the side effects of a drug. Pulmonary drug delivery systems utilize the respiratory mechanism to directly deliver drugs to a target region of the lungs. The drug molecules deposit in the mucus lining, on reaching the target region, and are simultaneously transported away from the target region due to mucociliary transport and molecular diffusion. The availability of drugs at a target lung region and hence, efficacy of the drugs, therefore, determined by the delivery and retention of the drugs at the target region. The present study computationally solves the coupled transport equations to identify the conditions conducive for drug delivery and retention in the deep lungs. Drug delivery efficacy to the deep lung is observed to be highest for 1–5 μ m aerosols. Breathing time period is also observed to influence efficacy. The amount of drugs deposited in the deep lung is observed to increase by a factor of 2 when the breathing time period is doubled with respect to normal breathing period. Such insights gained from this analysis will potentially help in devising mechanisms for increasing drug availability in the deep lung which is essential in achieving systemic drug delivery.

Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery

Numerical and Machine Learning Analysis of the Parameters Affecting the Regionally Delivered Nasal Dose of Nano- and Micro-Sized Aerosolized Drugs

In Silico Study on the Deposition and Distribution of Particles in a Realistic Airway Model with Handilaher®

Aerosol Deposition in Health and Disease

Numerical study on the deposition distribution and mechanism of inhaled drug particles in various regions of the realistic inhaler-airway model

Regional Aerosol Deposition in the Human Airways: the SimInhale Benchmark Case and a Critical Assessment of in Silico Methods

Deposition simulations of realistic dosages in patient-specific airways with two- and four-way coupling

Numerical and Experimental Analysis of Drug Inhalation in Realistic Human Upper Airway Model

The effects of airway disease on the deposition of inhaled drugs

Pulmonary drug delivery and retention: A computational study to identify plausible parameters based on a coupled airway-mucus flow model

An individualised 3D computational flow and particle model to predict the deposition of inhaled medicines - A case study using a nebuliser

Characterization of Pediatric Extrathoracic Aerosol Deposition with Air-Jet Dry Powder Inhalers

Rapid deposition analysis of inhaled aerosols in human airways

A 3D printed human upper respiratory tract model for particulate deposition profiling

Innovative preclinical models for pulmonary drug delivery research

Micron particle deposition in a tracheobronchial airway model under different breathing conditions

Deposition of Inhaled Particle in the Human Lungfor Different Age Groups

Designing Aerosol Therapies Based on the Integrated Evaluation of In Vitro, In Vivo, and In Silico Data

Numerical investigation of deposition mechanism in three mouth–throat models

A Critical Analysis of the CFD-DEM Simulation of Pharmaceutical Aerosols Deposition in Upper Intra-Thoracic Airways: Considerations on Aerosol Transport and Deposition

Inter-patient variability of inhaled medication lung deposition using Functional Respiratory Imaging (FRI)